Stockscreener 앱 받기
10.02
1.21%
0.07
시간 외 거래:
10.03
0.010
+0.10%
전일 마감가:
$9.95
열려 있는:
$10.17
하루 거래량:
140.42K
Relative Volume:
1.02
시가총액:
$191.24M
수익:
-
순이익/손실:
$-39.57M
주가수익비율:
-3.913
EPS:
-2.5607
순현금흐름:
$-36.97M
1주 성능:
+9.81%
1개월 성능:
-13.86%
6개월 성능:
+9.93%
1년 성능:
+77.92%
1일 변동 폭
$9.95
$10.74
1주일 범위
$9.35
$10.74
52주 변동 폭
$5.80
$14.93
Elicio Therapeutics Inc Stock (ELTX) Company Profile
명칭
Elicio Therapeutics Inc
전화
(857) 209-0050
주소
451 D STREET, 5TH FLOOR, BOSTON
Compare ELTX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
10.02 | 189.91M | 0 | -39.57M | -36.97M | -2.5607 |
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Elicio Therapeutics Inc Stock (ELTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Ladenburg Thalmann | Buy |
| 2026-03-10 | 개시 | Rodman & Renshaw | Buy |
Elicio Therapeutics Inc 주식(ELTX)의 최신 뉴스
Elicio Therapeutics (ELTX) Climbs +8.72% — Resistance at $10.47 in Focus 2026-05-20Crowd Sentiment Stocks - Newser
Liquidity Mapping Around (ELTX) Price Events - Stock Traders Daily
MIT: Big strides in cancer detection and treatment from the tiniest technologies - marketscreener.com
TradingKey - TradingKey
Elicio Therapeutics | 10-Q: Q1 2026 Earnings Report - Moomoo
Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates - The Manila Times
Elicio Therapeutics (NASDAQ:ELTX) Q1 2026 Results Show Extended Cash Runway Ahead of Key Phase 2 Data Readout - ChartMill
Elicio Therapeutics, Inc. 1Q 2026: Net income $(11.8M), EPS $(0.65) — 10-Q Summary - TradingView
Elicio Therapeutics: Q1 Earnings Snapshot - marketscreener.com
Elicio Therapeutics (NASDAQ: ELTX) warns on going concern as cash runs to Q4 2026 - Stock Titan
Elicio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Elicio Therapeutics (Nasdaq: ELTX) posts Q1 loss and extends cash runway - Stock Titan
What you need to know before buying Elicio Therapeutics (ELTX) (-1.00%) 2026-05-08Trending Stock Ideas - newser.com
Elicio Therapeutics Inc expected to post a loss of 46 cents a shareEarnings Preview - TradingView
Why (ELTX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
The one number that tells Elicio Therapeutics (ELTX) whole earnings story | Q4 2025: Earnings Beat EstimatesTurnaround Phase - newser.com
Elicio Therapeutics to Present at the Bank of America Healthcare Conference - The Manila Times
Elicio Therapeutics lines up May 14 investor webcast in Las Vegas - Stock Titan
elicio-ex311to10xk_aapri.htm - SEC.gov
elicio-ex312to10xk_aapri.htm - SEC.gov
Elicio Therapeutics | 10-K/A: Annual report (Amendment) - Moomoo
[10-K/A] Elicio Therapeutics, Inc. Amends Annual Report - Stock Titan
Elicio Therapeutics: Hoping To Capitalize On Massive KRAS Hype, But Time Is Running Out - Seeking Alpha
JonesTrading Initiates Elicio Therapeutics(ELTX.US) With Buy Rating, Announces Target Price $18 - Moomoo
Wall Street analysts predict a 42.28% upside in Elicio Therapeutics (ELTX): Here's what you should know - MSN
Understanding Momentum Shifts in (ELTX) - Stock Traders Daily
Is Elicio Therapeutics (ELTX) stock outperforming similar companies | Q4 2025: EPS Beats ForecastsCycle Outlook - Cổng thông tin điện tử tỉnh Lào Cai
ELTX (Elicio Therapeutics Inc.) narrowly tops Q4 2025 earnings estimates, shares post modest 0.43 percent gain today.Rating Upgrade - Cổng thông tin điện tử tỉnh Lào Cai
Elicio Therapeutics (ELTX) Stock Most Held Stocks (Technical Weakness) 2026-04-20Social Flow Trades - Xã Thanh Hà
Ladenburg Thalmann initiates coverage of Elicio Therapeutics (ELTX) with buy recommendation - MSN
Elicio Therapeutics (ELTX) Stock: Mid-Year Review (Trend Strengthens) 2026-04-18Stock Accumulation - Cổng thông tin điện tử tỉnh Lào Cai
New Elicio hire gets 21,210 stock options at $11.78 a share - Stock Titan
Avoiding Lag: Real-Time Signals in (ELTX) Movement - Stock Traders Daily
Elicio Therapeutics Reports Inducement Grants - ChartMill
ELTX SEC FilingsElicio Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Is Elicio Therapeutics (ELTX) Stock Attractive Now | ELTX Q4 Earnings: Beats Estimates by $0.00Cost Structure - Newser
Dip Buying: How do insiders feel about Elicio Therapeutics IncTrade Risk Assessment & Weekly Setup with High ROI Potential - baoquankhu1.vn
Aug Big Picture: Does Elicio Therapeutics Inc meet Warren Buffetts criteriaExit Point & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Will Elicio Therapeutics (ELTX) Stock Recover Soon | Price at $10.02, Down 2.65%Community Sell Signals - Cổng thông tin điện tử tỉnh Lào Cai
Aug Technicals: Does Elicio Therapeutics Inc meet Warren Buffetts criteriaQuarterly Market Review & Comprehensive Market Scan Insights - baoquankhu1.vn
Will Elicio Therapeutics (ELTX) Stock Hit Record Highs | Price at $9.90, Down 1.88%High Conviction Picks - Cổng thông tin điện tử tỉnh Lào Cai
ELTX PE Ratio & Valuation, Is ELTX Overvalued - Intellectia AI
JonesTrading Keeps Their Buy Rating on Elicio Therapeutics (ELTX) - The Globe and Mail
Discipline and Rules-Based Execution in ELTX Response - Stock Traders Daily
Elicio Therapeutics Inc (9HA.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Fund Flows: Is Elicio Therapeutics Inc a momentum stock2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
Can Elicio Therapeutics Inc lead its sector in growthMarket Volume Summary & Stock Timing and Entry Methods - baoquankhu1.vn
ELTX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Elicio Therapeutics (ELTX) price target increased by 12.90% to 17.85 - MSN
ELTX Stock Quote - richtv.io
Behavioral Patterns of ELTX and Institutional Flows - Stock Traders Daily
Elicio Therapeutics Inc (ELTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.49%
0.12%
자본화:
|
볼륨(24시간):